Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Resources Double-Crane Pharmaceutical Co Ltd stock Dividend Yield % is close to 3-year high.
During the past 12 months, China Resources Double-Crane Pharmaceutical Co's average Dividends Per Share Growth Rate was 31.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -15.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of China Resources Double-Crane Pharmaceutical Co was 63.90% per year. The lowest was -33.80% per year. And the median was 14.40% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
China Resources Double-Crane Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of China Resources Double-Crane Pharmaceutical Co was 0.73. The lowest was 0.09. And the median was 0.27.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
China Resources Double-Crane Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.100000
2025-10-28
2025-10-27
2025-10-28
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
China Resources Double-Crane Pharmaceutical Co's Dividend Yield (%) for Today is calculated as
Current Share Price is ¥17.11.
China Resources Double-Crane Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.1.
During the past 13 years, the highest Dividend Yield of China Resources Double-Crane Pharmaceutical Co was 4.49%. The lowest was 0.32%. And the median was 1.84%.
Good Sign:
China Resources Double-Crane Pharmaceutical Co Ltd stock Dividend Yield % is close to 3-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Double-Crane Pharmaceutical Co Dividends per Share Related Terms
China Resources Double-Crane Pharmaceutical Co Dividends per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Double-Crane Pharmaceutical Co Dividends per Share Chart
China Resources Double-Crane Pharmaceutical Co Annual Data
SHSE:600062 vs ZTS, UTHR: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Double-Crane Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
China Resources Double-Crane Pharmaceutical Co (SHSE:600062) has a Dividends per Share of ¥0.47 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on China Resources Double-Crane Pharmaceutical Co and its competitors.
Is China Resources Double-Crane Pharmaceutical Co's Dividends per Share too high?
China Resources Double-Crane Pharmaceutical Co's current Dividends per Share is ¥0.47. Overall, China Resources Double-Crane Pharmaceutical Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Resources Double-Crane Pharmaceutical Co's Dividends per Share compare to ZTS and UTHR?
China Resources Double-Crane Pharmaceutical Co's Dividends per Share of ¥0.47 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on China Resources Double-Crane Pharmaceutical Co and its competitors. China Resources Double-Crane Pharmaceutical Co's current Dividends per Share is ¥0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Double-Crane Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Double-Crane Pharmaceutical Co (SHSE:600062) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.83, compared to a current price of ¥17.11 — trading 9.1% below its estimated fair value. The current Dividends per Share is ¥0.47. China Resources Double-Crane Pharmaceutical Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For China Resources Double-Crane Pharmaceutical Co (SHSE:600062), the current Dividends per Share is ¥0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Double-Crane Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥17.11 is trading 9.1% below its estimated GF Value™ of ¥18.83.
GuruFocus considers China Resources Double-Crane Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600062:
Dividends per Share: ¥0.47
GF Value™: ¥18.83 vs. price of ¥17.11 (9.1% below fair value)
No single metric tells the full story. See the SHSE:600062 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Double-Crane Pharmaceutical Co Business Description
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
90GF Score
Get the complete analysis for SHSE:600062
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600062 has been successfully added to your 
